Daintain/AIF-1 Reinforces the Resistance of Breast Cancer Cells to Cisplatin

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioscience, biotechnology and biochemistry

• Publication date

  2012-12-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1271/bbb.120577PMID 23221708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway

  2012cited by this paper
• Platinum neurotoxicity pharmacogenetics

  2009cited by this paper
• DNA repair pathways as targets for cancer therapy

  2008cited by this paper
• Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.

  2008cited by this paper
• Daintain/AIF‐1 promotes breast cancer proliferation via activation of the NF‐κB/cyclin D1 pathway and facilitates tumor growth

  2008cited by this paper
• A Critical Role for Allograft Inflammatory Factor-1 in the Pathogenesis of Rheumatoid Arthritis

  2007cited by this paper
• Mechanisms of resistance to cisplatin and carboplatin.

  2007cited by this paper
• Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.

  2006cited by this paper
• Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli.

  2006cited by this paper
• A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples.

  2005cited by this paper
• DNA damage-induced apoptosis

  2004cited by this paper
• The role of copper transporters in the development of resistance to Pt drugs.

  2004cited by this paper
• Platinum-based chemotherapy in metastatic breast cancer: current status.

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• International variation

  2004cited by this paper
• Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.

  2003cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• The role of p53 in chemosensitivity and radiosensitivity

  2003cited by this paper
• Live or let die: the cell's response to p53

  2002cited by this paper
• Augmented Expression of Daintain/Allograft Inflammatory Factor‐1 is Associated with Clinical Disease: Dynamics of Daintain/Allograft Inflammatory Factor‐1 Expression in Spleen, Peripheral Nerves and Sera during Experimental Autoimmune Neuritis

  2000cited by this paper
• Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.

  1999cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• Apoptosis and the dilemma of cancer chemotherapy.

  1997cited by this paper
• A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.

  1997cited by this paper
• Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats.

  1997cited by this paper
• Coordinated Induction of MRP/GS-X Pump and γ-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells*

  1996cited by this paper
• Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

  1995cited by this paper

• AIF1: Function and Connection with Inflammatory Diseases

  2023cites this paper
• Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression

  2022cites this paper
• An isoform of AIF1 involved in breast cancer

  2018cites this paper
• miR-100 Reverses Cisplatin Resistance in Breast Cancer by Suppressing HAX-1

  2018cites this paper
• Une isoforme de Allograft Inflammatory Factor-1 (AIF1) impliquée dans le cancer du sein

  2018cites this paper
• Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer.

  2016cites this paper
• Quantitative proteomic profiling of pleomorphic human sarcoma identifies CLIC1 as a dominant pro-oncogenic receptor expressed in diverse sarcoma types.

  2014cites this paper
• Cisplatin Binding and Inactivation of Mitochondrial Glutamate Oxaloacetate Transaminase in Cisplatin-Induced Rat Nephrotoxicity

  2013cites this paper